A Prospective Comparative Study of Arthroscopic and Open Surgery in Cuistow Procedure
1 other identifier
interventional
70
1 country
1
Brief Summary
To evaluate the clinical outcomes of arthroscopic and open Chinese Unique Inlay Bristow procedure in treating recurrent anterior shoulder instability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2021
CompletedFirst Posted
Study publicly available on registry
July 7, 2021
CompletedStudy Start
First participant enrolled
November 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedDecember 9, 2021
July 1, 2021
1.1 years
June 27, 2021
November 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
ASES score
The American Shoulder and Elbow Surgeons (ASES) score is the most commonly used score to describe the function of patients' shoulder joints, ranging from 0 to 100. The higher the score, the better the function of patients' shoulder joints.
2 years after surgery
pain VAS score
The visual analog scale (VAS) for pain score is the most commonly used to describe pain levels in patients, ranging from 0 to 10, with a higher score indicating more intense pain.
2 years after surgery
Secondary Outcomes (4)
Active shoulder ranges of motion
2 years after surgery
Bone block position
immediately after surgery
Bone union
3 months after surgery
Bone union
2 years after surgery
Study Arms (2)
Arthroscopic Cuistow
EXPERIMENTALPatients who receive arthroscopic Cuistow procedure
Open Cuistow
EXPERIMENTALPatients who receive open Cuistow procedure
Interventions
Eligibility Criteria
You may qualify if:
- a glenoid defect ≥10%
- contact sport athletes with a glenoid defect \< 10%
- failure after Bankart repair.
You may not qualify if:
- epilepsy
- multidirectional shoulder instability
- concomitant other lesions including rotator cuff tear, symptomatic acromioclavicular joint pathology or pathological involvement of the long head of the biceps
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PekingUTH
Beijing, Beijing Municipality, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Guoqing Cui
Peking University Third Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 27, 2021
First Posted
July 7, 2021
Study Start
November 6, 2021
Primary Completion
December 30, 2022
Study Completion
December 30, 2023
Last Updated
December 9, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share